CryoCell International Inc (CCEL) is a Healthcare · Medical Care Facilities company listed on NYSE MKT. Price $4.01 (-5.65%), Market cap $0.03B, 52-week low–high $2.89 ~ $5.48.
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to
Financial statements, price targets, institutional (13F) holdings and related news for CryoCell International Inc are updated in real time on BlackAll Trade.
CryoCell International Inc trades at $4.01 (-5.65%). Real-time quotes and charts are available on BlackAll Trade.
CryoCell International Inc has a market cap of about $0.03B.
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primari